BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery
NCT00024362
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
INDUSTRY
Sponsor class
Conditions
Pancreatic Cancer
Interventions
DRUG:
BBR 3464
Sponsor
Theradex